Table 1.
Main initial characteristics of 80 patients with diffuse large B‐cell lymphoma
| Characteristics | No. (%) |
|---|---|
| Performance status (ECOG ≥ 2) | 20 (25) |
| B symptoms (n = 60) † | 24 (40) |
| Ann Arbor stage | |
| I | 8 (10) |
| II | 18 (22) |
| III | 19 (24) |
| IV | 35 (44) |
| Bulky disease (n = 76) † | 22 (29) |
| Bone marrow invasion (n = 77) † | 17 (22) |
| High serum LDH levels (> normal) | 40 (50) |
| Revised International Prognostic Index | |
| Very good risk | 11 (14) |
| Good risk | 32 (40) |
| Poor risk | 37 (46) |
| High serum sIL‐2R levels (>1500 U/mL) | 37 (46) |
| Primary extranodal origin (excluding Waldeyer's ring) | 34 (43) |
| Complete remission (CR) rate | 69 (86) |
| Overall response rate (CR + PR) | 73 (91) |
| Number of relapse | 14 (18) |
| Treated with hematopoietic stem cell transplantation | 5 (6) |
The median age of the patients was 66 years (range, 29–87 years); 41 were male and 39 were female.
†
The n shown reflects the number of patients for whom data were available.
ECOG, Eastern Cooperative Oncology Group scale; LDH, lactate dehydrogenase; PR, partial remission; sIL‐2R, soluble interleukin‐2 receptor.